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1. Introduction 
A number of compounds are known to have similar 
biological activity as the active form of vitamin Da, the 
hormonal metabolite la,25-dihydroxy-vitamin Da 
(ref [l] , la25-(OH)zDa). Among these active materials 
are 5,6 fransvitamin Da (B), dihydrotachysterol,(C), 
3-desoxy-lo-hydroxy-vitamin Da (D) their 25-hydroxy 
analogues as well as the clinically useful la-hydroxy- 
vitamin Da (A, la-HODa). All these compounds possess 
the vitamin Da skeleton substituted at position 1 with 
a hydroxy group having the same configuration as 
la-hydroxy-vitamin Da (these compounds are drawn 
up in the respective formulae as l/3-hydroxy deriva- 
tives which is their actual configuration, since they all 
possess the 6,7-s tram conformation). However, 
nothing, has been reported on the activity of vitamin 
Da analogues having the hydroxy group at C-l in the 
enantiomeric configuration. Thus in order to establish 
whether it is essential for the hydroxy function in 
vitamin D analogues to possess the o-configuration to 
elicit biological responses, it was necessary to synthe- 
size the l/3-hydroxy-vitamin Da (lo-HODa) and to 
determine its activity. 
2. Experimental 
2.1. Biological assays 
The biological response of the animals to vitamin D 
and its derivatives was assessed by daily dosing of the 
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steroids over seven days at which time the amounts of 
the vitamin and the analogues required to maintain an 
equivalent response was assessed [2]. This type of 
bioassay overcomes the problem of different time 
courses of response which arises in comparing the 
activity of the vitamin Da metabolites. 
The intestinal response of the chicks to these ste- 
roids was assessed by measuring the changes they 
effected in intestinal calcium-binding protein (CaBP) 
levels [3] or by measuring the proportion of an oral 
dose of 4SCa absorbed [4] . CaBP was determined by 
the Laurell method of immunoelectrophoresis using 
pure chick intestinal CaBP as standard. The degree of 
endochondrial calcification in rat tibia achieved by the 
steroids was determined by the radiographic method 
[5]. In a third type of assay the effect of these steroids 
on calcium mobilisation from bone of rats and chicks 
was assessed by recording the changes in plasma cal- 
cium levels effected by the steroids in animals on a 
low calcium diet. 
2.2. Chemical synthesis 
2.2.1. 1 -keto-previtamin Da (G) 
(i) A solution of 100 mg lahydroxy-vitamin D3 
(A) in 10 ml dry ethyl ether was treated at room 
temperature with 350 mg freshly prepared manga- 
nese dioxide for 6 h. The reaction mixture was filtered 
through a celite column and the filtrate was evapo- 
rated to dryness at room temperature. Chromato- 
graphy on silica gel using an ethyl acetate: chloroform 
mixture (3:7) resulted in 35 mg 1-keto-previtamin Da 
(G). NMR spectrum: 
6 ppm 0.74 (3H, s, 18-H), 1.69 (3H, s, 19-H) 5.99 
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and 6.13 (2H, AB q, J 11 Hz-, 6-H and 7-H), 5.51 
(IH, m, 9-H) and 4.02 (lH, heptet,/ 8.6 and 4.3 Hz, 
3-H); ultraviolet h,, 287,236 nm (E 10 000, 
9500). 
(ii) A solution of 100 mg of lo-hydroxy-previtamin 
D3 (F) in 10 ml ether was treated with 650 mg 
freshly prepared manganese dioxide for 6 h. Isolation 
as above resulted in 85 mg 1 -keto-previtamin Da (G). 
2.2.2. l/3-Hydroxy-previtamin Da (H) 
A solution of 50 mg I-keto-previtamin Da (G) in 
20 ml methanol was treated with 100 mg sodium 
borohydride at 0°C for 30 min, extracted with ether 
and washed with brine. The ethereal extract was dried 
over magnesium sulphate and evaporated at 0°C to 
dryness. The residue was chromatographed on silica 
gel. Elution with a mixture of ethyl acetate:chloro- 
form (3:7) gave 35 mg of lP-hydroxy-previtamin Da 
(H). NMR spectrum: 
6 ppm 0.70 (3H, s, 18-H), 1.70 (3H, s, 19-H) 5.56 
(lH, s, 9-H), 5.78 and 5.94 (2H, AB q, J 11.5 Hz, 
6-H and 7-H), 3.93 (lH, broad s, wi 11 Hz, 3-H) 
and 4.22 (lH, m, broad s, wi 10.5 Hz 1-H); ultra- 
violet, h,, 259 nm (e 10 000). 
2.2.3. IjI-Hydroxy-vitamin Da (E) 
A solution of 30 mg l/I-hydroxy-previtamin Da (H) 
in 10 ml iso-octane was heated under a nitrogen 
atmosphere at 60°C for 4 h. The solvent was evapo- 
rated to dryness and the residue was chromatographed 
on silica gel. Elution with ethyl either gave a yield of 
25 mg lj3-hydroxy-vitamin D3 (E). 
2.3. Other chemicals and methods 
lcu-(OH)Da was synthesised as described previously 
[6] and vitamin D3 was a crystalline product obtained 
from Sigma. 
Plasma calcium levels were determined by atomic 
absorption spectroscopy and protein was determined 
spectrophotometrically. 
Animals, Rhode Island Red X Light Sussex chicks 
(1 day old) were raised on a vitamin D-deficient diet 
and used after 4 weeks when they were deficient [7]. 
Piebald weanling rats were raised on a low phosphate 
vitamin D-deficient diet for two weeks by which time 
they were rachitic. In the appropriate experiments 
groups of animals were placed on a low calcium vita- 
min D-deficient diet. The steroids were dissolved in 
propylene glycol and administered orally at appro- 
priate levels. 
3. Results and discussion 
In none of the vitamin D-sensitive biological 
responses used in this study could an effect with 
l&(OH)Da be obtained. As much as 10 pg of this 
steroid did not produce any detectable amount 
of CaBP in chick intestine. Since 0.5 pg of vitamin 
Ds gives a readily measurable amount of this protein 
(table 1) the potency of this compound in stimu- 
Table 1 
Relative effectiveness of vitamin D,, la- and lp-hydroxy-vitamin D, in chick 
intestinal CaBP synthesis and rat endochondral calcification 
Compound Dose level 
(gg) 
CaBP levels 
(gg/mg protein) 
Dose level 
(ng) 
Calcification 
score 
Vitamin D, 0.5 9.2 50 3.4 
1.0 24.6 100 4.3 
2.0 34.0 200 6.9 
lor(OH)D, 
2.0 35.9 50 2.6 
4.0 42.5 100 5.3 
lo-(OH)D, 10.0 ND 200 0 
Vitamin D-deficient birds and rats were dosed daily so as to receive the amounts 
indicated over 7 days. 24 h later the birds were killed and intestinal cytosol pre- 
pared for estimation of CaBP (3). ND, no observable precipition line whatsoever. 
The rats were X-rayed after 7 days and 14 days and the degree of healing assess- 
ed. The scores are those obtained after 14 days 
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Fig.1. Structures of lwHOD, (A); 5,6-trunsvitamin D, (B); 
dihydrotachysterol, (C); 3-desoxy-lor-hydroxyvitamin D,
(D). 
lating CaBP synthesis must be assessed as less than 5% 
of vitamin Ds. Experience with other compounds with 
very low vitamin D activity suggests that the activity 
of lb-(0H)Ds is less than 1% of the activity of the 
parent vitamin. Similar findings were obtained in the 
other bioassay systems so that for example 0.25 pg 
of the I@-(0H)Ds failed to produce any effect on 
calcification in the rat or on elevation of plasma cal- 
cium in rat or chick. In both of these latter systems a 
good response was obtained to increasing amounts of 
both vitamins Da and lo-(OH)Ds. 
In the course of this work the 1 -keto-vitamin Da 
compound was prepared, but it was found to be 
unstable and to undergo rapid re-arrangement to 
1-keto-previtamin Ds. The biological activity of the 
l-keto-vitamin Ds compound was also low in that 
0.5 pg was unable to increase the proportion of an 
oral dose of 45Ca absorbed whereas 125 ng of vitamin 
Da gave a measurable response. 
Since the discovery of 1,25-(OH),Da as the active 
form of vitamin D3 there have been several studies in the 
different systems responsive to it of the features of the 
molecule necessary for biological activity (see ref. [l] for 
recent review). There are several convincing pieces of 
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Fig.2. Routes for synthesis of lp-HOD,. I@-hydroxyvitamin D, (E); lor-hydroxy-previtamin D, (F); l-keto-previtamin D, (G); 
lp-hydroxy-previtamin D, (H). 
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information that the natural form of the hormone has the References 
hydroxyl group at C-l in the a-position. Thus the inser- 
tion of this hydroxyl group by the 1 -hydroxylase to form [l] Schnoes, H. K. and DeLuca, H. F. (1976) Ann. Revs. 
1 ,2.5-(OH)*D3 involves loss of 3H specifically located 
Biochem. 46, 631-666. 
r3j Holick, M. F., Kasten-Schraufrogel, P., Tavela, T. and 
in the la-position of the substrate [7] . Furthermore 
chemical syntheses have been described which yield 
specifically lc~25-(OH)~D~ and the biological potency 
of this material corresponds completely with the bio- 
logically produced substance [8]. The synthesis of 
l/3-(HO)D3 described here and its very low biological 
potency confirms that the natural 1,25-(OH)zD3 has 
an almost absolute requirement for the 1 -hydroxyl 
group to be in the a-position (i.e., above the plane of 
the A ring of the vitamin D molecule). 
‘-’ 
131 
[41 
I51 
161 
DeLuca, H. F. (1975) Arch. Biochem. Biophys. 166, 
63-66. 
Bar, A. and Wasserman, R. H. (1974) J. Nutr. 104, 
1202-1207. 
[71 
181 
Emtage, J. S., Lawson, D. E. M. and Kodicek, E. (1974) 
Biochem. J. 144,339-346. 
Kodicek, E. and Lawson, D. E. M. (1967) in: The Vitamin? 
(Gyorgy, P. and Pearson, W. N. eds) pp. 21 l-244, Acad. 
Press, New York. 
Freeman, D., Archer, A. and Mazur, Y. (1975) Tetra- 
hedron Lett. 43, 261-265. 
Lawson, D. E. M., Wilson, P. W. and Kodicek, E. (1969) 
Biochem. J. 115, 269-277. 
Semmler, E. J., Holick, M. F., Schnoes, H. K. and DeLuca, 
H. F. (1972) Tetrahedron Lett. 40,4147-4151. 
140 
